Researchers identify medulloblastoma molecular groups using noninvasive MRI spectroscopy
Research by Stefan Blüml, Ph.D., and colleagues investigates the use of in vivo proton magnetic resonance spectroscopy (¹H-MRS) to identify medulloblastoma molecular subgroups before surgery, a noninvasive alternative to surgical tumor sampling that could help support treatment planning at an earlier stage. The study is published in the journal Neuro-Oncology.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
